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Abstract The three-component reactions of substituted
pyridines, dimethyl acetylenedicarboxylates, and 3-phenacy-
lideneoxindoles afforded spiro[indoline-3,1′-quinolizines] in
high yields and with high diastereoselectivity. The Diels–
Alder reactions of spiro[indoline-3,1′-quinolizines] with
maleic anhydride and N -phenyl maleimides successfully
resulted in polyfunctionalized isoquinolinuclidine deriva-
tives. The similar three-component reactions with quino-
line resulted in the novel spiro[indoline-3,4′-pyrido[1,2-
a]quinolines] in moderate to good yields.
Keywords Multicomponent reaction · MCR ·
Domino reaction · Diels–Alder reaction · Spirooxindole ·
Isoquinolinuclidine · Spiro[indoline-3,1′-quinolizines]
Introduction
The spirooxindole core is a privileged heterocyclic ring sys-
tem that is featured in a large number of bioactive nat-
urally occurring alkaloids and medicinally relevant com-
pounds [1–5]. Due to the exceptional high reactivity of the 3-
carbonyl group, 3-methylene and 3-phenacylideneoxindoles
have attracted a lot of attention for synthetic reactions,
especially multicomponent reactions [6–8] and catalytic
asymmetric reactions [9–11] in the past few years. As a
result, numerous elegant transformations have been devel-
oped for the diastereoselective and enantioselective construc-
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tion of versatile spirooxindole skeletons [12–17]. For the
synthesis of these challenging heterocycles, the 1,4-dipolar
cycloaddition of Huisgen 1,4-dipoles, which were gener-
ated from reactions of nitrogen heterocycles with electron-
deficient alkynes, has proven to be a convenient and effi-
cient synthetic methodology [18,19]. Nair et al. [20] first
reported the three-component reaction of pyridine, dimethyl
acetylenedicarboxylate (DMAD), and N -benzylisatins to
give spiro[indololine-3,2′-pyrido[2,1-b][1,3]oxazine]. Later,
Yavari [21] and Nair [22] reported the similar reactions
of quinoline and isoquinoline with DMAD and isatins for
the preparation of complex spirooxindole derivatives. Shi
and co-workers [23] found that the three-component reac-
tions of pyridine, DMAD, and N -substituted isatylidene
derivatives afforded spiro[indoline-3,2-quinolizine] in high
yields and with good diastereoselectivities. Recently, we
successfully developed an efficient synthetic protocol for
dispirooxindole-fused heterocycles via the domino reac-
tion of p-dimethylaminopyridine and DMAD with two
molecules of 3-phenacylideneoxindoles [24]. In order to
demonstrate the synthetic utility of this practical method,
herein we wish to report the three-component reaction
of azaarenes such as substituted pyridines and quino-
line with DMAD and 3-phenacylideneoxindoles and 3-
ethoxycarbonylmethyleneoxindoles for the synthesis of spiro
[indoline-3,1′-quinolizine] derivatives and their potential
applications as effective dienes for Diels–Alder reactions.
Results and discussion
We initiated our studies by evaluating the reactivity of
the Huisgen 1,4-dipoles generated from the reaction of
alkylpyridines with DMAD. According to our previously
established conditions for the reaction of 4-dimethylaminopy-
ridine [24], the three-component reactions of 2-picoline with
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pyridine (1.2 mmol), DMAD
(1.2 mmol) and
3-phenacylideneoxindole (1.0
mmol) in THF (10.0 mL), rt, 6 h
aIsolated yield
1a–1o
Entry Compd. R Ar R′ R′′ Yielda (%)
1 1a 2-CH3 p-CH3C6H4 H Bn 66
2 1b 2-CH3 p-CH3C6H4 CH3 n-C4H9 53
3 1c 3-CH3 p-CH3OC6H4 H Bn 61
4 1d 3-CH3 m-CH3OC6H4 F Bn 58
5 1e 3-CH3 p-CH3C6H4 Cl Bn 62
6 1f 3-CH3 p-CH3OC6H4 F n-C4H9 74
7 1g 4-CH3 p-CH3OC6H4 F n-C4H9 77
8 1h 4-CH3 p-CH3OC6H4 Cl n-C4H9 75
9 1i 4-CH3O p-CH3OC6H4 Cl Bn 89
10 1j 4-CH3O p-CH3C6H4 Cl Bn 84
11 1k 4-CH3O p-CH3OC6H4 F Bn 91
12 1l 4-CH3O p-CH3C6H4 F Bn 87
13 1m 4-CH3O C6H5 F Bn 81
14 1n 4-CH3O p-CH3OC6H4 Cl n-C4H9 93
15 1o 4-CH3O p-CH3C6H4 F n-C4H9 90
DMAD and 3-phenacylideneoxindoles in THF at room tem-
perature proceeded very smoothly to give the expected 2′,9a′-
dihydrospiro[indoline-3,1′-quinolizine] 1a–1b in moderate
yields (Table 1, entries 1–2). Under similar conditions, the
reactions with 3-picoline and 4-picoline gave the correspond-
ing spiro products 1c–1h in high yields (Table 1, entries 3–8).
When 4-methoxypyridine was utilized in the reactions, much
higher yields of spiro compounds 1j–1o (Table 1, entries
9–15) were obtained.
The structures of the prepared 2′,9a′-dihydrospiro[indoline-
3,1′-quinolizin]-2-ones 1a–1n were fully characterized by
1H NMR, 13C NMR, HRMS, and IR. The 1H NMR spec-
tra of the spiro compounds 1a–1n usually show one set of
signals for the characteristic groups in the molecule, which
clearly indicated that only one diastereoisomer existed in
each sample. The molecular structures of compounds 1f
(Fig. 1), 1h (SPI, Fig. s1), and 1m (SPI, Fig. s2) were success-
fully confirmed by single-crystal X-ray diffraction. These
three molecules (1f, 1h, 1m) have the same stereochem-
istry. In the newly formed tetrahydropyridyl ring, the two
protons at 2- and 4-positions are in cis-orientation. The ben-
zoyl and aryl groups of the oxindole moiety also exist in
cis-position. It is reported that the benzoyl group and aryl
group of oxindole moiety exist in cis-position in the starting
3-phenacylideneoxindoles [25,26] indicating that this con-
figuration is expected to be retained in the reaction. Thus,
we unambiguously ascertained that compounds 1a–1o are
Fig. 1 ORTEP representation of crystal structure of spiro compound
1f
the cis-isomers proving that this three-component reaction
undergoes with very high diastereoselectivity.
It should be pointed out that spiro compounds 1i–1o
derived from the reactions with 4-methoxypyridine are not
very stable in solution because of the presence of a reac-
tive methyl vinyl ether moiety. The 4-methoxy group could
be slowly transformed into the 4-carbonyl group during the
purification process when dissolved in THF, DCM, ethyl
acetate, and toluene (Scheme 1). The structures of the two
spiro compounds 2a–2b were successfully characterized via
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2a: R' = H, R" = Bn, Ar = C6H4CH3-p
2b: R' = Cl, R" = Bn, Ar = C6H4CH3-p
Scheme 1 Formation of 2,8′-dioxo-2′,8′,9′,9a′-tetrahydrospiro[indo-
line-3,1′-quinolizines]
spectroscopic methods, and the structure of spiro compound
2b was also confirmed by X-ray diffraction (SPI, Fig. s3).
To further demonstrate the substrate scope and the
diastereoselectivity of this three-component reaction, quino-
line was also utilized in the reaction. The three-component
reaction of quinoline, DMAD, and 3-phenacylideneoxindoles
in THF usually resulted in a complex mixture. After explor-
ing different solvents, we were pleased to find that the reac-
tion proceeded smoothly in DME to give the desired 3′,4a′-
dihydrospiro[indoline-3,4′-pyrido[1,2-a]quinolines] 3a–3e
in moderate yields after thin-layer chromatography (Table 2,
entries 1–5). Under similar conditions, the reactions with 3-
ethoxycarbonylmethyleneoxindoles afforded the spiro
[indoline-3,4′-pyrido[1,2-a]quinolines] 3f–3j with much
better yields (Table 2, entries 6–10). The structures of spiro
compounds 3a–3j were also confirmed using spectroscopic
methods and compounds 3e and 3i were further confirmed
by X-ray diffraction (Figs. 2, 3, respectively). A stereochem-
istry similar to that of 1a–1o was observed for the spiro com-
pounds 3a–3j, in which the two protons at 2- and 4-positions
Fig. 2 X-ray structure of spiro compound 3e
existed in cis-orientation in the newly formed tetrahydropy-
ridyl ring, and the benzoyl group and the aryl group of the
oxindole moiety also existed in cis-position. These results
also indicate that this three-component reaction is a high
diastereoselective reaction.
There is a 1,2-dihydropyridyl moiety in the above-
prepared dihydrospiro[indoline-3,1′-quinolizin]-2-ones 1a–
1n. 1,2-Dihydropyridine is an effective diene for Diels–
Alder reaction to construct versatile bridged heterocyclic
compounds [27–33]. Thus, we proceeded to investigate the
role of our spiro compounds 1a–1n as dienophiles in Diels–
Alder reactions. The reaction of dihydrospiro[indoline-3,1′-
quinolizines] with a slight excess of N -phenyl maleimides





(1.5 mmol), DMAD (1.5 mmol),
and 3-methyleneoxindole (1.0
mmol) in DME (10.0 mL), rt, 6
h aIsolated yield
3a–3j
Entry Compd. R R′ E Yielda (%)
1 3a Cl Bn C6H4CH3-p 40
2 3b Cl Bn C6H4Cl-p 52
3 3c F Bn C6H5 55
4 3d F Bn C6H4Cl-p 53
5 3e Cl n-C4H9 C6H4OCH3-p 60
6 3f CH3 Bn OEt 50
7 3g H Bn OEt 63
8 3h Cl Bn OEt 70
9 3i Cl n-Bu OEt 73
10 3j F Bn OEt 65
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Fig. 3 X-ray structure of spiro compound 3i
or maleic anhydride proceeded smoothly in refluxing 1,2-
dimethoxyethane for 6 h to give the desired 1,4-cycloaddition
products 4a–4g in satisfactory yields (Table 3). 1H NMR data
and single-crystal determination of compound 4d (Fig. 4)
indicated that the configuration of previous dihydrospiro
[indoline-3,1′-quinolizine] moiety is retained and the
maleimide unit exists in exo-configuration in this Diels–
Alder reaction.
Conclusion
In summary, an efficient protocol for the synthesis of func-
tionalized spiro[indoline-3,1′-quinolizine] and spiro[indoline-
3,4′-pyrido[1,2-a]quinoline] was successfully developed by
three-component reactions of nitrogen heterocycles, DMADs,
and 3-methyleneoxindoles. This MCR reaction can proceed
smoothly under mild conditions to afford complex hete-
rocycles in moderate to good yields and high diastereos-
Fig. 4 ORTEP representation of crystal structure of spiro compound
4d
electivities. Furthermore, the prepared spiro[indoline-3,1′-
quinolizines] can undergo Diels–Alder reactions with maleic
anhydride and N -phenyl maleimides to give complex iso-
quinolinuclidine derivatives. The simplicity of the procedure,
readily available substrates, and ease of handling render this
protocol applicable for the synthesis of structurally diverse
heterocyclic compounds.
Experimental section
General procedure for the three-component reaction
of substituted pyridine, DMAD, and
3-phenacylideneoxindoles
A mixture of substituted pyridine (1.2 mmol), DMAD (1.2
mmol, 0.170 g), and 3-phenacylideneoxindole (1.0 mmol) in
10.0 mL of tetrahydrofuran was stirred at room temperature
for 6 h. Then, the solvent was removed by evaporation and
the residue was subjected to thin-layer chromatography (15×





(1.0 mmol) and N -substituted
maleimide or maleic anhydride




Entry Compd. R Ar R′ R′′ Z Yielda (%)
1 4a 4-CH3 p-CH3OC6H4 F Bn NC6H5 80
2 4b 4-CH3 p-CH3C6H4 Cl Bn NC6H5 77
3 4c 4-CH3 p-CH3OC6H4 F n-C4H9 NC6H4CH3-p 72
4 4d 4-CH3 p-CH3OC6H4 F n-C4H9 NC6H4Cl-p 85
5 4e 3-CH3 p-CH3OC6H4 F n-C4H9 NC6H4Cl-p 86
6 4f 4-OCH3 p-CH3OC6H4 Cl n-C4H9 O 90
7 4g 4-OCH3 p-CH3C6H4 F n-C4H9 O 88
123
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25 cm SiO2 plate) with a mixture of light petroleum and ethyl
acetate (V/V = 2:1) as the developing reagent. The product
was separated from silica gel by eluting with ethanol and is





Yellow solid, 66 %, m.p. 173–175 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.26 (br s, 2H, ArH), 7.20 (br s, 2H, ArH),
7.15–7.13 (m, 4H, ArH), 7.06 (br s, 2H, ArH), 6.89 (br s, 3H,
ArH), 6.58 (br s, 1H, CH), 5.60 (brs, 1H, CH), 5.27 (s, 1H,
CH), 4.98 (br s, 1H, CH), 4.61 (br s, 2H, CH), 4.50 (br s, 1H,
CH), 3.87 (s, 3H, OCH3), 3.56 (s, 3H, OCH3), 2.32 (s, 3H,
CH3), 1.93 (s, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ:
196.5, 174.2, 166.3, 166.1, 146.7, 143.4, 136.8, 135.1, 134.9,
128.9, 128.6, 128.4, 128.2, 127.4, 127.1, 126.9, 125.4, 124.9,
122.1, 116.1, 113.9, 108.5, 103.1, 66.8, 58.4, 53.3, 52.2, 49.2,
43.9, 21.7, 20.6; IR (KBr) υ: 3447, 2946, 2025, 1732, 1710,
1685, 1655, 1611, 1578, 1489, 1465, 1437, 1405, 1368, 1291,
1232, 1177, 1129, 1080, 1017, 963, 815, 793, 738 cm−1;





Yellow solid, 53 %, m.p. 161–163 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.39 (d, J = 7.8 Hz, 2H, ArH), 7.18 (d, J
= 7.2 Hz, 2H, ArH), 7.03–7.01 (m, 2H, ArH), 6.73 (d, J =
7.8 Hz, 1H, ArH), 6.21 (d, J = 7.8 Hz, 1H, CH), 5.50–5.47
(m, 1H, CH), 5.23 (s, 1H, CH), 4.93–4.91 (m, 1H, CH), 4.65
(d, J = 9.6 Hz, 1H, CH), 3.95 (s, 3H, OCH3), 3.39 (s, 3H,
OCH3), 3.24–3.21 (m, 1H, CH), 3.08–3.04 (m, 1H, CH),
2.32 (s, 3H, CH3), 2.24 (s, 3H, CH3), 1.67 (s, 3H, CH3),
0.95 (br s, 3H, CH), 0.69 (t, J = 7.2 Hz, 3H, CH3); 13C NMR
(150 MHz, DMSO-d6) δ: 196.9, 172.8, 165.1, 164.3, 144.4,
143.2, 139.4, 130.6, 128.9, 128.6, 128.0, 127.8, 127.7, 126.7,
121.1, 121.0, 107.9, 101.9, 63.7, 53.3, 53.0, 51.3, 44.5, 28.4,
21.1, 21.0, 19.4, 13.5; IR (KBr) υ: 3452, 2952, 2869, 2025,
1747, 1698, 1659, 1615, 1582, 1496, 1436, 1362, 1269, 1237,
1151, 1115, 1083, 1048, 936, 866, 827, 779, 740, 701 cm−1;





Yellow solid, 61 %, m.p. 190–192 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.51 (d, J = 7.8 Hz, 2H, ArH), 7.18 (t, J =
7.2 Hz, 1H, ArH), 7.11 (t, J = 7.8 Hz, 4H, ArH), 6.98–6.93
(m, 3H, ArH), 6.81 (d, J = 7.2 Hz, 2H, ArH), 6.69 (d, J =
7.8 Hz, 1H, ArH), 6.05 (s, 1H, CH), 5.54 (d, J = 8.4 Hz, 1H,
CH), 5.35 (s, 1H, CH), 4.91–4.90 (m, 2H, CH), 4.64 (d, J =
15.7 Hz, 1H, CH), 4.49 (d, J = 15.7 Hz, 1H, CH), 3.95 (s, 3H,
OCH3), 3.82 (s, 3H, OCH3), 3.43 (s, 3H, OCH3), 1.43 (s,
3H, CH3); 13C NMR (150 MHz, CDCl3) δ: 195.8, 174.8,
166.1, 165.3, 163.3, 145.6, 142.6, 135.2, 130.5, 130.4, 128.6,
128.5, 128.2, 127.6, 127.5, 126.9, 125.9, 123.0, 122.5, 116.0,
113.4, 109.5, 108.6, 104.6, 62.7, 55.4, 54.1, 53.4, 51.6, 47.4,
43.9, 17.5; IR (KBr) υ: 3450, 2949, 2843, 2026, 1742, 1708,
1674, 1609, 1582, 1510, 1489, 1464, 1434, 1412, 1380, 1308,
1244, 1172, 1125, 1021, 983, 941, 899, 825, 776, 746 cm−1;





Yellow solid, 58 %, m.p. 172–173 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.36 (brs, 1H, ArH), 7.18–7.13 (m, 5H, ArH),
7.05–7.00 (m, 2H, ArH), 6.85 (br s, 3H, ArH), 6.74 (br s,
1H, ArH), 6.11 (s, 1H, CH), 5.59 (br s, 1H,CH), 5.41 (s,
1H, CH), 4.97–4.93 (m, 2H, CH), 4.60 (br s, 1H,CH), 4.48
(br s, 1H,CH), 3.97 (s, 3H, OCH3), 3.73 (s, 3H, OCH3),
3.45 (s, 3H, OCH3), 1.47 (s, 3H, CH3); 13C NMR (150
MHz, CDCl3) δ: 197.1, 174.4, 165.5 (d, J = 134.6 Hz),
159.5, 145.7, 138.8, 138.7, 134.9, 129.3, 128.8, 128.5, 127.7,
126.9, 122.5, 120.8, 120.3, 115.7, 115.5 (d, J = 24.9 Hz),
115.1 (d, J = 24.3 Hz), 111.5, 109.7, 109.1 (d, J = 5.7 Hz),
104.3, 62.6, 55.4, 54.4, 53.4, 51.7, 47.9, 44.1, 17.5; IR (KBr)
υ: 3451, 2948, 2839, 2025, 1742, 1710, 1612, 1582, 1486,
1452, 1433, 1410, 1342, 1294, 1251, 1194, 1176, 1117, 1050,
1009, 983, 946, 896, 868, 841, 813, 788, 752 cm−1; MS





Yellow solid, 62 %, m.p. 169–172 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.48 (d, J = 7.8 Hz, 2H, ArH), 7.24 (d, J =
7.8 Hz, 3H, ArH), 7.19 (t, J = 7.2 Hz, 1H, ArH), 7.12–7.09
(m, 3H, ArH), 6.76 (d, J = 7.2 Hz, 2H, ArH), 6.72 (d, J
= 8.4 Hz, 1H, ArH), 6.11 (s, 1H, CH), 5.59 (d, J = 9.6 Hz,
1H, CH), 5.42 (s, 1H, CH), 4.96 (s, 1H, CH), 4.91 (d, J =
9.6 Hz, 1H, CH), 4.64 (d, J = 15.6 Hz, 1H, CH), 4.45 (d, J =
15.6 Hz, 1H, CH), 3.97 (s, 3H, OCH3), 3.43 (s, 3H, OCH3),
2.36 (s, 3H, CH3), 1.47 (s, 3H, CH3); 13C NMR (150 MHz,
CDCl3) δ: 196.7, 174.2, 165.9, 165.1, 145.6, 143.7, 141.2,
134.8, 134.7, 129.0, 128.7, 128.6, 128.4, 127.8, 127.6, 126.9,
123
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122.6, 115.5, 109.8, 109.6, 104.6, 62.6, 54.3, 53.5, 51.7, 47.7,
43.9, 21.7, 17.5; IR (KBr) υ: 3446, 3040, 2948, 2853, 2025,
1716, 1680, 1611, 1584, 1482, 1434, 1404, 1371, 1295, 1243,
1178, 1115, 1076, 983, 942, 899, 801, 743, 703 cm−1; MS





Yellow solid, 74 %, m.p. 162–163 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.44 (d, J = 9.0 Hz, 2H, ArH), 7.09 (td, J1 =
9.0 Hz, J2 = 2.4 Hz, 1H, ArH), 6.90–6.89 (m, 3H, ArH), 6.82
(dd, J1 = 8.7 Hz, J2 = 2.4 Hz, 1H, ArH), 6.09 (s, 1H, CH),
5.62 (d, J = 9.6 Hz, 1H, CH), 5.28 (s, 1H, CH), 4.92–4.90
(m, 1H, CH), 4.88 (brs, 1H, CH), 3.96 (s, 3H, OCH3), 3.79
(s, 3H, OCH3), 3.42 (s, 3H, OCH3), 3.40–3.36 (m, 1H, CH),
3.25–3.21 (m, 1H, CH), 1.48 (s, 3H, CH3), 0.99–0.91 (m,
3H, CH), 0.79–0.73 (m, 1H, CH), 0.69 (t, J = 7.2 Hz, 3H,
CH3); 13C NMR (150 MHz, DMSO-d6) δ: 195.8, 174.0,
165.9, 165.1, 163.3, 158.9 (d, J = 119.5 Hz), 145.5, 138.9,
130.5, 130.4, 128.2, 127.9, 127.8, 122.5, 115.8, 115.6 (d, J =
25.2 Hz), 114.9 (d, J = 23.9 Hz), 113.3, 109.6, 108.1 (d, J =
8.3 Hz), 104.3, 62.2, 55.3, 54.1, 53.3, 51.6, 47.4, 40.0, 29.1,
20.0, 17.5, 13.6; IR (KBr) υ: 3453, 2955, 2924, 2867, 2025,
1746, 1708, 1680, 1600, 1582, 1490, 1455, 1403, 1368, 1329,
1305, 1262, 1237, 1172, 1107, 1076, 1027, 1000, 981, 952,
895, 849, 815, 758 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 77 %, m.p. 164–166 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.42 (d, J = 7.2 Hz, 2H, ArH), 7.08 (br s,
1H, ArH), 6.89 (d, J = 7.2 Hz, 3H, ArH), 6.79 (d, J = 7.8 Hz,
1H, ArH), 6.33 (d, J = 7.2 Hz, 1H, CH), 5.26 (s, 1H, CH),
4.88 (s, 1H, CH), 4.73 (d, J = 7.2 Hz, 1H, CH), 4.61 (s,
1H, CH), 3.95 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.44 (s,
3H, OCH3), 3.36 (br s, 1H, CH), 3.29 (br s, 1H, CH), 1.38
(s, 3H, CH3), 1.06 (brs, 1H, CH), 0.98–0.97 (m, 2H, CH),
0.86 (brs, 1H, CH), 0.71 (br s, 3H, CH3); 13C NMR (150
MHz, CDCl3) δ: 195.9, 174.1, 165.8, 164.9, 163.3, 145.4,
139.0, 132.6, 130.5, 130.4, 128.0, 127.9, 126.6, 115.5 (d,
J = 25.2 Hz), 114.9 (d, J = 24.3 Hz), 113.6, 113.5, 113.3,
112.1, 110.2, 108.0 (d, J = 8.3 Hz), 105.8, 104.7, 63.1, 56.9,
55.4, 54.4, 53.4, 51.7, 47.5, 40.0, 29.4, 29.1, 20.8, 20.5, 20.1,
20.0, 13.7; IR (KBr) υ: 3449, 2953, 2927, 2867, 2026, 1734,
1700, 1671, 1595, 1490, 1437, 1377, 1313, 1278, 1245, 1200,
1174, 1141, 1120, 1023, 952, 885, 853, 816, 790, 755, 729
cm−1; MS (m/z): HRMS (ESI) Calcd. for C33H34FN2O7




Yellow solid, 75 %, m.p. 168–171 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.43 (d, J = 7.8 Hz, 2H, ArH), 7.29 (d, J =
7.8 Hz, 1H, ArH), 7.02 (s, 1H, ArH), 6.90 (t, J = 8.4 Hz, 3H,
ArH), 6.33 (d, J = 7.8 Hz, 1H, CH), 5.27 (s, 1H, CH), 4.89 (s,
1H, CH), 4.73 (d, J = 7.2 Hz, 1H, CH), 4.60 (s, 1H, CH), 3.95
(s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.44 (s, 3H, OCH3), 3.37
(brs, 1H, CH), 3.29–3.26 (m, 1H, CH), 1.38 (s, 3H, CH3),
1.05 (br s, 1H, CH), 0.99–0.95 (m, 2H, CH), 0.86 (br s, 1H,
CH), 0.71 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (150 MHz,
CDCl3) δ: 195.7, 173.9, 165.8, 164.9, 163.3, 145.4, 141.6,
132.7, 130.4, 128.4, 127.9, 127.8, 127.7, 126.5, 113.3, 110.1,
108.5, 106.0, 104.7, 63.2, 55.4, 54.4, 53.4, 51.7, 47.5, 39.9,
29.1, 20.8, 20.0, 13.7; IR (KBr) υ: 3456, 3071, 2952, 2869,
2587, 2027, 1742, 1710, 1672, 1605, 1579, 1511, 1483, 1432,
1381, 1324, 1243, 1173, 1127, 1045, 1023, 982, 955, 913,
869, 836, 810, 730 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 89 %, m.p. 150.0–150.3 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.54 (d, J = 7.2 Hz, 2H, ArH), 7.25
(d, J = 6.6 Hz, 1H, ArH), 7.18 (d, J = 6.6 Hz, 1H, ArH), 7.13
(br s, 2H, ArH), 7.01 (s, 1H, ArH), 6.97–6.95 (m, 4H, ArH),
6.82 (d, J = 7.8 Hz, 1H, ArH), 6.43 (d, J = 7.8 Hz, 1H, CH),
5.36 (s, 1H, CH), 5.05 (s, 1H, CH), 4.66 (d, J = 7.2 Hz, 1H,
CH), 4.60–4.54 (m, 2H, CH2), 3.95 (s, 3H, OCH3), 3.82 (s,
3H, OCH3), 3.77 (brs, 1H, CH), 3.47 (s, 3H, OCH3), 2.93
(s, 3H, OCH3); 13C NMR (150 MHz, CDCl3) δ: 195.5,
174.5, 165.7, 164.8, 163.5, 153.7, 145.2, 141.4, 135.0, 130.7,
130.6, 130.2, 128.8, 128.6, 128.4, 127.8, 127.7, 127.5, 127.1,
113.5, 113.4, 109.1, 100.2, 83.0, 64.0, 58.4, 55.5, 55.3, 54.1,
53.5, 53.4, 51.9, 47.3, 43.9, 18.4, 15.3; IR (KBr) υ: 3457,
2954, 1745, 1707, 1671, 1628, 1600, 1511, 1484, 1455,
1435, 1377, 1339, 1251, 1226, 1178, 1136, 979, 944, 902,
868, 845, 808, 757 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 84 %, m.p. 162.3–163.1 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.42 (d, J = 7.8 Hz, 2H, ArH), 7.27–
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7.24 (m, 3H, ArH), 7.18 (d, J = 7.2 Hz, 1H, ArH), 7.14 (t, J
= 7.2 Hz, 2H, ArH), 7.00 (s, 1H, ArH), 6.96 (d, J = 7.8 Hz,
2H, ArH), 6.82 (d, J = 8.4 Hz, 1H, ArH), 6.43 (d, J = 8.4 Hz,
1H, CH), 5.37 (s, 1H, CH), 5.06 (s, 1H, CH), 4.66 (d, J =
7.2 Hz, 1H, CH), 4.49 (br s, 2H, CH2), 3.95 (s, 3H, OCH3),
3.75 (brs, 1H, CH), 3.48 (s, 3H, OCH3), 2.91 (s, 3H, OCH3),
2.36 (s, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ: 196.8,
174.4, 173.4, 165.7, 164.8, 153.7, 145.2, 143.7, 141.4, 135.1,
135.0, 134.8, 129.2, 128.9, 128.8, 128.7, 128.5, 128.3, 127.9,
127.8, 127.7, 127.5, 127.3, 126.9, 100.1, 83.0, 63.9, 55.1,
54.0, 53.5, 51.9, 47.8, 43.9, 21.7, 21.6; IR (KBr) υ: 3455,
2945, 1744, 1716, 1672, 1626, 1600, 1480, 1456, 1432, 1388,
1370, 1317, 1246, 1231, 1175, 1135, 1043, 977, 947, 918,
869, 838, 814, 784 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 91 %, m.p. 147.1–148.0 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.54 (d, J = 8.4 Hz, 2H, ArH), 7.18
(t, J = 7.2 Hz, 1H, ArH), 7.13 (d, J = 7.2 Hz, 2H, ArH), 7.04
(t, J = 8.4 Hz, 1H, ArH), 6.96 (t, J = 7.8 Hz, 4H, ArH), 6.79–
6.78 (m, 2H, ArH), 6.43 (d, J = 7.8 Hz, 1H, CH), 5.35 (s, 1H,
CH), 5.04 (d, J = 3.0 Hz, 1H, CH), 4.65 (d, J = 6.6 Hz, 1H,
CH), 4.56 (brs, 2H, CH2), 3.95 (s, 3H, OCH3), 3.83 (s, 3H,
OCH3), 3.78 (br s, 1H, CH), 3.47 (s, 3H, OCH3), 2.93 (s, 3H,
OCH3); 13C NMR (150 MHz, DMSO-d6) δ: 195.3, 173.6,
165.0, 164.0, 163.3, 157.9 (d, J = 236.9 Hz), 153.0, 144.8,
139.1, 135.6, 130.2, 129.6, 129.3, 128.5, 127.4, 127.3, 127.2,
115.1 (d, J = 23.1 Hz), 114.3 (d, J = 28.2 Hz), 113.6, 109.4
(d, J = 6.2 Hz), 106.1, 99.7, 82.8, 63.3, 56.0, 55.5, 54.5, 53.8,
53.4, 51.6, 46.4, 43.0, 18.5; IR (KBr) υ: 3450, 1737, 1641,
1488, 1422, 1369, 1285, 1232, 1187, 1111, 952, 865, 816,
774 cm−1; MS (m/z): HRMS (ESI) Calcd. for C36H32FN2O8




Yellow solid, 87 %, m.p. 158.5–159.0 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.42 (d, J = 7.8 Hz, 2H, ArH), 7.24
(t, J = 7.8 Hz, 2H, ArH), 7.18 (t, J = 7.2 Hz, 1H, ArH), 7.14
(t, J = 7.2 Hz, 2H, ArH), 7.06 (t, J = 8.4 Hz, 1H, ArH), 6.97
(t, J = 7.2 Hz, 2H, ArH), 6.81–6.77 (m, 2H, ArH), 6.43 (d,
J = 8.4 Hz, 1H, CH), 5.37 (s, 1H, CH), 5.05 (d, J = 8.4 Hz,
1H, CH), 4.66 (d, J = 7.8 Hz, 1H, CH), 4.48 (brs, 2H, CH2),
3.95 (s, 3H, OCH3), 3.76 (brs, 1H, CH), 3.48 (s, 3H, OCH3),
2.91 (s, 3H, OCH3), 2.36 (s, 3H, CH3); 13C NMR (150 MHz,
CDCl3) δ: 196.9, 174.6, 165.7, 164.8, 159.0 (d, J = 240 Hz),
153.6, 145.2, 143.7, 138.8, 135.2 134.8, 128.9, 128.8, 128.3,
127.7, 115.4 (d, J = 25.4 Hz), 115.1 (d, J = 23.4 Hz), 108.7
(d, J = 7.5 Hz), 106.5, 100.2, 83.1, 63.9, 55.2, 54.1, 53.5,
51.8, 47.7, 43.9, 21.6; IR (KBr) υ: 3454, 2946, 1745, 1715,
1675, 1625, 1597, 1487, 1454, 1434, 1387, 1317, 1297, 1243,
1227, 1179, 1153, 1128, 1045, 981, 947, 892, 868, 843, 809,
767 cm−1; MS (m/z): HRMS (ESI) Calcd. for C36H32FN2O7




Yellow solid, 81 %, m.p. 137.2–137.6 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.63 (brs, 1H, ArH), 7.46–7.44 (m,
4H, ArH), 7.17 (brs, 3H, ArH), 7.08 (brs, 1H, ArH), 7.02
(brs, 2H, ArH), 6.83–6.77 (m, 2H, ArH), 6.44 (d, J = 8.4 Hz,
1H, CH), 5.39 (s, 1H, CH), 5.06 (brs, 1H, CH), 4.66 (d,
J = 5.4 Hz, 1H, CH), 4.46 (d, J = 15.0 Hz, 1H, CH), 4.36
(d, J = 15.0 Hz, 1H, CH), 3.96 (s, 3H, OCH3), 3.75 (br s,
1H, CH), 3.50 (s, 3H, OCH3), 2.88 (s, 3H, OCH3); 13C
NMR (150 MHz, CDCl3) δ: 197.5, 174.5, 165.7, 164.7,
159.0 (d, J = 239.9 Hz), 153.6, 145.2, 138.9, 137.5, 135.3,
132.9, 128.8, 128.7, 128.2, 128.1, 127.8, 127.6, 115.4 (d, J =
21.2 Hz), 115.2 (d, J = 19.7 Hz), 108.7 (d, J = 8.4 Hz), 106.3,
100.3, 83.1, 63.8, 55.1, 54.0, 53.5, 51.9, 48.1, 43.9; IR (KBr)
υ: 3450, 2948, 1752, 1712, 1647, 1631, 1598, 1488, 1436,
1388, 1335, 1296, 1227, 1155, 1131, 1051, 980, 940, 908,
894, 862, 826, 768 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 93 %, m.p. 162.1–163.0 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.41 (d, J = 8.4 Hz, 2H, ArH), 7.30
(dd, J1 = 8.4 Hz, J2 = 1.8 Hz, 1H, ArH), 6.98 (d, J = 1.8 Hz,
1H, ArH), 6.90 (dd, J1 = 5.7 Hz, J2 = 3.0 Hz, 3H, ArH),
6.43 (d, J = 7.8 Hz, 1H, CH), 5.26 (s, 1H, CH), 4.98 (d, J
= 3.0 Hz, 1H, CH), 4.70 (dd, J1 = 7.8 Hz, J2 = 1.8 Hz, 1H,
CH), 3.95 (s, 3H, OCH3), 3.85 (br s, 1H, CH), 3.79 (s, 3H,
OCH3), 3.47 (s, 3H, OCH3), 3.38–3.33 (m, 1H, CH), 3.30–
3.27 (m, 1H, CH), 3.18 (s, 3H, OCH3), 1.10–1.05 (m, 1H,
CH), 1.00–0.96 (m, 2H, CH), 0.94–0.89 (m, 1H, CH), 0.71
(t, J = 7.2 Hz, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ:
195.7, 174.1, 165.7, 164.8, 163.3, 163.2, 153.6, 145.2, 141.8,
130.4, 128.8, 128.6, 128.0, 127.7, 125.8, 113.6, 113.3, 108.4,
106.8, 102.5, 100.1, 83.1, 63.7, 57.6, 55.4, 55.2, 54.1, 53.4,
51.8, 47.5, 39.9, 29.3, 20.1, 13.6; IR (KBr) υ: 3450, 2953,
1737, 1713, 1670, 1626, 1601, 1574, 1510, 1483, 1459, 1432,
1384, 1323, 1246, 1175, 1133, 1116, 1027, 979, 940, 915,
873, 848, 812, 780 cm−1; MS (m/z): HRMS (ESI) Calcd. for
C33H34ClN2O8 ([M+H]+): 621.1998. Found: 621.1997.
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Yellow solid, 90 %, m.p. 176.7–177.2 ◦C; 1H NMR (600
MHz, DMSO-d6) δ: 7.28 (d, J = 8.4 Hz, 2H, ArH), 7.17 (d,
J = 7.8 Hz, 2H, ArH), 7.10 (td, J1 = 9.0 Hz, J2 = 2.4 Hz, 1H,
ArH), 6.87 (dd, J1 = 8.4 Hz, J2 = 4.2 Hz, 1H, ArH), 6.75 (dd,
J1 = 8.4 Hz, J2 = 2.4 Hz, 1H, ArH), 6.43 (d, J = 7.8 Hz, 1H,
CH), 5.27 (s, 1H, CH), 4.97 (d, J = 3.6 Hz, 1H, CH), 4.70 (dd,
J1 = 8.4 Hz, J2 = 2.4 Hz, 1H, CH), 3.95 (s, 3H, OCH3), 3.86
(br s, 1H, CH), 3.48 (s, 3H, OCH3), 3.30–3.20 (m, 2H, CH),
3.18 (s, 3H, OCH3), 2.31 (s, 3H, CH3), 1.09–1.03 (m, 1H,
CH), 1.02–0.97 (m, 2H, CH), 0.92–0.85 (m, 1H, CH), 0.72
(t, J = 7.2 Hz, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ:
197.2, 174.1, 165.7, 164.8, 158.9 (d, J = 239.4 Hz), 153.5,
145.2, 143.5, 139.2, 135.0, 129.1, 128.8, 128.3, 128.1, 115.4
(d, J = 25.1 Hz), 107.9 (d, J = 8.3 Hz), 106.6, 102.6, 100.2,
83.2, 63.6, 57.6, 55.1, 54.1, 53.4, 51.8, 47.8, 39.9, 29.2,
21.6, 20.1, 13.7; IR (KBr) υ: 3452, 2951, 1751, 1709, 1676,
1629, 1599, 1491, 1456, 1437, 1378, 1322, 1275, 1229, 1197,
1181, 1159, 1134, 1048, 1005, 975, 940, 901, 868, 839, 823,
761 cm−1; MS (m/z): HRMS (ESI) Calcd. for C33H34FN2O7




White solid, m.p. 188.8–188.9 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.59 (br s, 2H, ArH), 7.36 (br s, 1H, ArH),
7.19–7.13 (m, 8H, ArH), 6.80 (br s, 2H, ArH), 6.56 (brs,
1H, CH), 5.28 (br s, 2H, CH), 4.46 (d, J = 13.2 Hz, 1H,
CH), 4.39 (d, J = 15.6 Hz, 1H, CH), 4.29 (d, J = 15.6 Hz,
1H, CH), 4.06 (s, 3H, OCH3), 3.51 (s, 3H, OCH3), 2.40
(s, 3H, CH3), 2.22 (d, J = 15.6 Hz, 1H, CH), 1.89 (t, J =
15.6 Hz, 1H, CH); 13C NMR (150 MHz, CDCl3) δ: 195.4,
190.3, 174.3, 165.3, 164.0, 144.4, 142.7, 134.6, 134.0, 129.6,
129.2, 128.8, 128.6, 127.7, 127.1, 127.0, 124.2, 123.9, 109.6,
107.3, 106.0, 59.0, 53.8, 52.0, 51.8, 45.9, 44.2, 36.1, 21.7;
IR (KBr) υ: 3453, 1752, 1715, 1664, 1637, 1593, 1487,
1466, 1453, 1367, 1326, 1292, 1254, 1218, 1183, 1129, 1106,
945, 904, 795, 754 cm−1; MS (m/z): HRMS (ESI) Calcd. for




White solid, m.p. 181.1–181.3 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.89 (br s, 2H, ArH), 7.59 (br s, 1H, ArH),
7.47 (br s, 1H, ArH), 7.29 (br s, 5H, ArH), 7.13 (br s, 4H, ArH,
CH), 5.34 (s, 1H, CH), 4.91 (brs, 2H, CH), 4.66–4.63 (m, 2H,
CH), 3.99 (s, 3H, OCH3), 3.47 (s, 3H, OCH3), 2.38 (s, 3H,
CH3), 1.87 (br s, 2H, CH); 13C NMR (150 MHz, CDCl3) δ:
197.6, 190.3, 172.4, 164.9, 164.0, 144.7, 144.2, 144.0, 141.0,
135.1, 134.7, 129.8, 129.6, 129.4, 128.9, 128.7, 128.1, 127.6,
125.5, 110.7, 107.7, 102.6, 54.9, 53.8, 52.3, 51.0, 44.2, 43.3,
36.3, 21.7; IR (KBr) υ: 3452, 2956, 1740, 1713, 1678, 1633,
1594, 1479, 1439, 1383, 1326, 1300, 1249, 1186, 1131, 1081,
1002, 956, 936, 898, 883, 855, 815, 781, 737, 704 cm−1; MS
(m/z): HRMS (ESI) Calcd. for C35H30ClN2O7 ([M+H]+):
625.1736. Found: 625.1745.
General procedure for the three-component reaction of
quinoline, DMAD, and 3-methyleneoxindoles
A mixture of quinoline (1.5 mmol), DMAD (1.5 mmol,
0.213 g), and 3-methyleneoxindole (1.0 mmol) in 10.0 mL of
dimethoxyethane (DME) was stirred at room temperature for
6 h. Then, the solvent was removed by evaporation and the
residue was quickly subjected to thin-layer chromatography
(15 × 25 cm SiO2 plate) with a mixture of light petroleum




Yellow solid, 40 %, m.p. 183–186 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.36 (br s, 2H, ArH), 7.23 (b rs, 2H, ArH),
7.16 (br s, 4H, ArH), 6.98–6.93 (m, 2H, ArH), 6.86 (br s, 4H,
ArH), 6.65 (br s, 1H, ArH), 6.57 (br s, 1H, ArH), 6.33 (d, J =
5.4 Hz, 1H, CH), 5.42 (s, 1H, CH), 5.33 (brs, 1H, CH), 4.72–
4.61 (br s, 3H, CH), 3.88 (s, 3H, OCH3), 3.61 (s, 3H, OCH3),
2.33 (s, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ: 195.4,
173.8, 166.0, 165.2, 146.1, 143.7, 141.5, 138.1, 134.7, 134.6,
129.9, 129.2, 129.1, 128.7, 128.5, 128.4, 128.1, 127.8, 127.7,
126.9, 126.7, 122.4, 121.6, 118.9, 118.0, 114.7, 109.2, 65.0,
59.3, 53.1, 52.3, 49.4, 44.1; IR (KBr) υ: 3448, 2949, 1721,
1701, 1683, 1640, 1571, 1490, 1432, 1382, 1356, 1302, 1242,
1179, 1114, 972, 817 cm−1; MS (m/z): HRMS (ESI) Calcd.




Yellow solid, 52 %, m.p. 171–173 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.45 (br s, 4H, ArH), 7.22 (br s, 4H, ArH),
7.02 (br s, 1H, ArH), 6.87 (brs, 5H, ArH), 6.66 (br s, 2H,
ArH), 6.35 (br s, 1H, CH), 5.45 (br s, 1H, CH), 5.34 (br
s, 1H, CH), 4.76–4.64 (m, 3H, CH), 3.89 (s, 3H, OCH3),
3.62 (s, 3H, OCH3); 13C NMR (150 MHz, DMSO-d6) δ:
194.8, 172.6, 165.4, 164.4, 150.5, 144.9, 141.7, 138.6, 137.5,
135.9, 135.2, 135.0, 129.8, 129.5, 128.9, 128.5, 128.3, 128.1,
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128.0, 127.9, 127.4, 127.0, 126.1, 125.8, 122.4, 121.4, 118.6,
118.3, 113.9, 110.1, 64.3, 58.0, 53.1, 48.7, 43.2; IR (KBr) υ:
3448, 2949, 1722, 1702, 1641, 1614, 1490, 1433, 1401, 1382,
1356, 1304, 1241, 1190, 1130, 1090, 1015, 968, 917, 850, 817
cm−1; MS (m/z): HRMS (ESI) Calcd. for C38H29Cl2N2O6




Yellow solid, 55 %, m.p. 166–167 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.58 (br s, 1H, ArH), 7.41–7.36 (m, 4H, ArH),
7.21 (br s, 4H, ArH), 6.95–6.80 (m, 6H, ArH), 6.56 (br s, 1H,
ArH), 6.41–6.40 (m, 1H, ArH), 6.34–6.33 (m, 1H, CH), 5.44
(s, 1H, CH), 5.32 (d, J = 6.6 Hz, 1H, CH), 4.68–4.61 (m, 3H,
CH), 3.89 (s, 3H, OCH3), 3.63 (s, 3H, OCH3); 13C NMR
(150 MHz, DMSO-d6) δ: 195.8, 172.9, 165.5, 164.5, 157.2
(d, J = 236.4 Hz), 150.5, 145.0, 139.3, 137.5, 136.5, 136.0,
135.3, 133.4, 129.8, 128.6, 127.9, 127.8, 127.6, 127.4, 126.9,
126.2 (d, J = 8.7 Hz), 122.3, 121.4, 118.7, 118.5, 115.5 (d,
J = 25.7 Hz), 114.8 (d, J = 23.0 Hz), 113.9, 109.5 (d, J =
8.3 Hz), 64.3, 58.4, 53.1, 52.3, 48.9, 43.3; IR (KBr) υ: 3448,
2952, 1737, 1711, 1633, 1605, 1571, 1491, 1437, 1407, 1383,
1360, 1180, 1114, 1081, 1014, 967, 875, 819, 768 cm−1; MS





Yellow solid, 53 %, m.p. 170–171 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.45 (br s, 4H, ArH), 7.22 (br s, 4H, ArH),
6.90 (br s, 6H, ArH), 6.65 (br s, 1H, ArH), 6.42–6.35 (m, 2H,
ArH, CH), 5.44 (s, 1H, CH), 5.35 (brs, 1H, CH), 4.76–4.65
(m, 3H, CH), 3.88 (s, 3H, OCH3), 3.62 (s, 3H, OCH3); 13C
NMR (150 MHz, DMSO-d6) δ: 194.8, 172.8, 165.5, 164.4,
157.3 (d, J = 239.1 Hz), 144.9, 139.2, 138.5, 137.5, 135.3,
135.1, 129.8, 129.5, 128.9, 128.5, 127.9, 127.8, 127.4, 127.0,
126.0 (d, J = 9.2 Hz), 122.4, 121.5, 118.5, 115.6 (d, J =
17.0 Hz), 115.0 (d, J = 18.6 Hz), 113.9, 109.6, 64.3, 58.1,
53.1, 52.3, 48.7, 43.3; IR (KBr) υ: 3450, 2949, 1712, 1634,
1570, 1491, 1454, 1431, 1405, 1382, 1351, 1245, 1178, 1092,
967, 852, 820, 776 cm−1; MS (m/z): HRMS (ESI) Calcd. for




Yellow solid, 60 %, m.p. 186–189 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.34 (br s, 2H, ArH), 7.22 (br s, 1H, ArH),
7.05 (br s, 1H, ArH), 6.93 (brs, 1H, ArH), 6.87 (br s, 4H,
ArH), 6.76 (br s, 1H, ArH), 6.62 (br s, 1H, ArH), 6.35
(br s, 1H, CH), 5.44 (s, 1H, CH), 5.32–5.29 (m, 2H, CH),
4.59 (s, 1H, CH), 3.88 (s, 3H, OCH3), 3.76 (s, 3H, OCH3),
3.61 (s, 3H, OCH3), 3.44 (brs, 2H, CH), 1.03–1.02 (m, 4H,
CH), 0.76 (brs, 3H, CH3); 13C NMR (150 MHz, DMSO-
d6) δ: 194.1, 172.5, 165.5, 164.6, 163.2, 144.9, 142.2, 137.6,
129.9, 129.8, 129.5, 128.1, 128.0, 127.8, 126.5, 125.3, 122.2,
121.4, 118.9, 118.4, 113.8, 113.7, 109.4, 64.0, 58.3, 55.4,
53.0, 52.2, 48.9, 28.7, 19.4, 13.5; IR (KBr) υ: 3452, 2947,
1739, 1716, 1680, 1603, 1572, 1490, 1434, 1381, 1355, 1309,
1252, 1210, 1179, 1135, 1022, 968, 883, 816, 779 cm−1; MS





Yellow solid, 50 %, m.p. 117–115 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.38–7.18 (m, 6H, ArH), 6.94–6.82 (m, 5H,
ArH), 6.52 (br s, 1H, ArH), 6.29 (br s, 1H, CH), 5.35 (b rs,
1H, CH), 5.02 (br s, 1H, CH), 4.88 (br s, 1H, CH), 4.50 (s,
1H, CH), 4.26 (s, 1H, CH), 3.87 (s, 3H, OCH3), 3.70 (s, 3H,
OCH3), 3.35–3.54 (m, 2H, CH2), 1.74 (s, 3H, CH3), 0.38–
0.37 (m, 3H, CH3); 13C NMR (150 MHz, DMSO-d6) δ:
173.2, 168.1, 165.3, 164.7, 144.8, 141.1, 137.7, 136.1, 130.0,
129.4, 128.7, 128.5, 127.8, 127.6, 127.5, 127.4, 124.6, 122.1,
121.5, 118.9, 115.8, 114.0, 108.4, 63.9, 60.2, 58.2, 53.0,
52.2, 47.0, 43.3, 20.0, 12.8; IR (KBr) υ: 3452, 2951, 1742,
1709, 1604, 1572, 1496, 1457, 1435, 1381, 1352, 1307, 1253,
1218, 1184, 1161, 1119, 1088, 1019, 981, 810, 776 cm−1;





Yellow solid, 63 %, m.p. 176–177 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.42–7.37 (m, 4H, ArH), 7.30 (br s, 1H, ArH),
7.17 (br s, 1H, ArH), 7.05 (brs, 1H, ArH), 6.92 (br s, 2H,
ArH), 6.85–6.82 (m, 2H, ArH), 6.69 (br s, 1H, ArH), 6.52
(br s, 1H, ArH), 6.32 (br s, 1H, CH), 5.38 (br s, 1H, CH),
5.06 (d, J = 15.0 Hz, 1H, CH), 4.90 (d, J = 15.0 Hz, 1H, CH),
4.56 (s, 1H, CH), 4.28 (s, 1H, CH), 3.86 (s, 3H, OCH3), 3.70
(s, 3H, OCH3), 3.53 (br s, 1H, CH), 3.48 (brs, 1H, CH),
0.33 (brs, 3H, CH3); 13C NMR (150 MHz, DMSO-d6) δ:
173.4, 168.1, 165.3, 164.6, 145.0, 143.6, 137.3, 136.0, 129.6,
128.8, 128.5, 127.7, 127.6, 127.5, 126.5, 124.7, 122.3, 121.4,
121.1, 118.9, 115.3, 113.9, 109.0, 64.1, 60.3, 58.0, 53.0, 52.2,
48.0, 43.3, 12.8; IR (KBr) υ: 3452, 2950, 1740, 1707, 1610,
1571, 1493, 1463, 1435, 1384, 1357, 1307, 1282, 1252, 1221,
123
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1177, 1132, 1087, 1020, 981, 902, 875, 831, 813, 783 cm−1;





Yellow solid, 70 %, m.p. 173–174 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.39–7.36 (m, 4H, ArH), 7.31–7.30 (m, 1H,
ArH), 7.20 (t, J = 7.8 Hz, 1H, ArH), 7.13 (d, J = 8.4 Hz, 1H,
ArH), 6.95–6.90 (m, 3H, ArH), 6.84 (d, J = 7.2 Hz, 1H, ArH),
6.60 (brs, 1H, ArH), 6.35 (d, J = 9.6 Hz, 1H, CH), 5.37 (dd,
J1 = 9.6 Hz, J2 = 3.6 Hz, 1H, CH), 5.07 (d, J = 15.6 Hz, 1H,
CH), 4.90 (d, J = 15.6 Hz, 1H, CH), 4.58 (s, 1H, CH), 4.29
(s, 1H, CH), 3.87 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.61–
3.56 (m, 2H, CH2), 0.42 (t, J = 7.2 Hz, 3H, CH3); 13C NMR
(150 MHz, DMSO-d6) δ: 172.9, 168.1, 165.2, 164.5, 144.6,
142.4, 137.3, 135.7, 129.8, 128.6, 128.0, 127.7, 127.6, 126.9,
126.5, 125.5, 122.4, 121.3, 118.5, 115.7, 113.7, 110.3, 63.7,
60.5, 58.3, 53.1, 52.3, 47.8, 43.4, 12.8; IR (KBr) υ: 3448,
2949, 1735, 1712, 1603, 1570, 1493, 1457, 1434, 1364, 1341,
1311, 1250, 1212, 1179, 1140, 1087, 1016, 977, 812, 775
cm−1; MS (m/z): HRMS (ESI) Calcd. for C34H30ClN2O7




Yellow solid, 73 %, m.p. 158–159 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.20–7.18 (m, 2H, ArH), 7.05 (d, J = 7.8 Hz,
1H, ArH), 6.92–6.91 (m, 2H, ArH), 6.86–6.85 (m, 1H, ArH),
6.65 (br s, 1H, ArH), 6.38 (d, J = 9.6 Hz, 1H, CH), 5.37 (d, J
= 6.6 Hz, 1H, CH), 4.52 (s, 1H, CH), 4.21 (s, 1H, CH), 3.87
(s, 3H, OCH3), 3.74 (br s, 2H, CH2), 3.69 (s, 3H, OCH3),
3.63–3.62 (m, 2H, CH2), 1.57 (brs, 2H, CH2), 1.35–1.34 (m,
2H, CH2), 0.93 (br s, 3H, CH3), 0.61 (brs, 3H, CH3); 13C
NMR (150 MHz, DMSO-d6) δ: 172.6, 172.6, 168.1, 165.2,
164.5, 144.6, 142.8, 137.4, 129.8, 128.6, 127.9, 127.6, 126.9,
126.6, 125.2, 122.4, 121.3, 118.5, 115.6, 113.8, 109.9, 63.5,
60.4, 58.2, 53.0, 52.2, 47.9, 29.0, 19.4, 13.5, 13.1; IR (KBr)
υ: 3454, 2956, 1744, 1713, 1639, 1614, 1598, 1570, 1490,
1433, 1378, 1355, 1325, 1303, 1247, 1212, 1183, 1135,
1116, 1021, 989, 969, 944, 914, 868, 822, 780 cm−1; MS





Yellow solid, 65 %, m.p. 160–163 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.40–7.37 (m, 4H, ArH), 7.30 (br s, 1H, ArH),
7.20 (br s, 1H, ArH), 7.94–7.63 (m, 4H, ArH), 6.85 (br s, 1H,
ArH), 6.43 (br s, 1H, ArH), 6.36 (d, J = 8.4 Hz, 1H, CH),
5.40 (br s, 1H, CH), 5.08 (d, J = 15.6 Hz, 1H, CH), 4.90 (d, J
= 15.6 Hz, 1H, CH), 4.60 (s, 1H, CH), 4.30 (s, 1H, CH), 3.87
(s, 3H, OCH3), 3.70 (s, 3H, OCH3), 3.59–3.55 (m, 2H, CH2),
0.38 (brs, 3H, CH3); 13C NMR (150 MHz, CDCl3) δ:
174.0, 168.6, 165.8, 165.1, 158.1 (d, J = 239.6 Hz), 145.6,
139.7, 137.9, 135.3, 129.8, 128.8, 128.2, 128.0, 127.9, 127.6,
127.1 (d, J = 7.8 Hz), 122.5, 121.6, 118.3, 115.9, 115.6 (d,
J = 26.0 Hz), 115.0 (d, J = 23.3 Hz), 114.4, 109.0 (d, J
= 8.0 Hz), 64.5, 60.9, 59.3, 53.1, 52.2, 48.4, 44.4, 13.3; IR
(KBr) υ: 3451, 2950, 1739, 1708, 1608, 1571, 1494, 1456,
1436, 1344, 1307, 1252, 1226, 1175, 1131, 1020, 979, 900,
875, 827, 775 cm−1; MS (m/z): HRMS (ESI) Calcd. for
C34H30FN2O7 ([M+H]+): 597.2032. Found: 597.2034.
General procedure for the Diels–Alder reaction
of spiro[indoline-3,1′-quinolizines]
A mixture of spiro[indoline-3,1′-quinolizine] (1.0 mmol) and
N -substituted maleimide or maleic anhydride (1.5 mmol) in
10.0 mL of DME was refluxed for 12 h. Then, the solvent
was removed by evaporation and the residue was subjected to
thin-layer chromatography with a mixture of light petroleum
and ethyl acetate (V/V = 2:1) as the developing reagent to
give the pure spiro compound 4a–4g.
Spiro compounds (4a)
White solid, 80 %, m.p. 297–298 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.60 (d, J = 8.4 Hz, 2H, ArH), 7.44 (t, J
= 7.8 Hz, 2H, ArH), 7.38 (t, J = 7.2 Hz, 1H, ArH), 7.19
(t, J = 7.2 Hz, 1H, ArH), 7.14 (t, J = 7.2 Hz, 2H, ArH),
7.05 (t, J = 8.4 Hz, 1H, ArH), 6.99–6.97 (m, 6H, ArH), 6.79
(dd, J1 = 9.0 Hz, J2 = 4.2 Hz, 1H, ArH), 6.61–6.60 (m, 1H,
ArH), 5.77 (d, J = 5.4 Hz, 1H, CH), 5.20 (s, 1H, CH), 4.59
(br s, 2H, CH2), 4.32–4.31 (m, 1H, CH), 4.15 (s, 1H, CH),
4.00 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.54 (dd, J1 =
7.5 Hz, J2 = 3.0 Hz, 1H, CH), 3.48 (dd, J1 = 7.5 Hz, J2 =
3.0 Hz, 1H, CH), 3.34 (br s, 3H, OCH3), 2.66 (s, 1H, CH),
0.52 (s, 3H, CH3); 13C NMR (150 MHz, DMSO-d6) δ:
194.6, 175.1, 174.5, 174.1, 165.3, 164.5, 163.1, 157.7 (d,
J = 236.4 Hz), 146.5, 140.6, 138.5, 135.6, 131.8, 130.1,
129.8, 129.0, 128.6, 128.5, 127.5, 127.4, 126.6, 126.0 (d, J =
9.5 Hz), 122.6, 117.2 (d, J = 24.8 Hz), 114.6 (d, J = 23.6 Hz),
113.5, 109.8 (d, J = 7.2 Hz), 94.6, 60.7, 55.5, 53.3, 51.9, 50.8,
49.8, 45.9, 43.1, 42.2, 38.5, 18.9; IR (KBr) υ: 3450, 2951,
123
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1778, 1711, 1670, 1590, 1488, 1459, 1434, 1376, 1345, 1324,
1244, 1176, 1123, 1033, 987, 950, 903, 843, 811 cm−1; MS
(m/z): HRMS (ESI) Calcd. for C46H39FN3O9 ([M+H]+):
796.2665. Found: 796.2670.
Spiro compounds (4b)
White solid, 77 %, m.p. >300 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.49 (d, J = 7.8 Hz, 2H, ArH), 7.43 (t, J
= 7.8 Hz, 2H, ArH), 7.38 (t, J = 7.8 Hz, 1H, ArH), 7.26–7.25
(m, 3H, ArH), 7.19 (t, J = 7.2 Hz, 1H, ArH), 7.14 (t, J =
7.2 Hz, 2H, ArH), 7.00–6.99 (m, 4H, ArH), 6.83–6.82 (m,
2H, ArH), 5.74 (d, J = 5.4 Hz, 1H, CH), 5.21 (s, 1H, CH),
4.54 (br s, 2H, CH2), 4.32–4.30 (m, 1H, CH), 4.15 (s, 1H,
CH), 4.00 (s, 3H, OCH3), 3.54 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz,
1H, CH), 3.47 (dd, J1 = 7.5 Hz, J2 = 3.0 Hz, 1H, CH), 3.35
(s, 3H, OCH3), 2.64 (s, 1H, CH), 2.37 (s, 3H, CH3), 0.50 (s,
3H, CH3); 13C NMR (150 MHz, CDCl3) δ: 196.0, 175.0,
174.7, 173.8, 166.0, 165.1, 146.8, 143.7, 141.7, 140.9, 135.0,
134.7, 131.3, 131.1, 129.3, 129.0, 128.9, 128.4, 128.3, 128.0,
127.4, 126.6, 126.1, 109.8, 96.5, 61.6, 53.7, 52.1, 51.3, 50.4,
46.0, 44.2, 42.6, 39.2, 21.6, 19.4; IR (KBr) υ: 3452, 2952,
1781, 1712, 1641, 1483, 1430, 1384, 1322, 1233, 1186, 1129,
949, 887, 803 cm−1; MS (m/z): HRMS (ESI) Calcd. for
C46H39ClN3O8 ([M+H]+): 796.2420. Found: 796.2429.
Spiro compounds (4c)
White solid, 72 %, m.p. 173–175 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.46 (d, J = 8.4 Hz, 2H, ArH), 7.22 (d, J =
7.8 Hz, 2H, ArH), 7.09 (t, J = 8.4 Hz, 1H, ArH), 6.91–6.86
(m, 5H, ArH), 6.57 (d, J = 6.6 Hz, 1H, ArH), 5.81 (d, J
= 4.2 Hz, 1H, CH), 5.09 (s, 1H, CH), 4.31 (br s, 1H, CH),
4.04 (s, 1H, CH), 4.00 (s, 3H, OCH3), 3.80 (s, 3H, OCH3),
3.53–3.52 (m, 1H, CH), 3.46–3.45 (m, 1H, CH), 3.37 (brs,
1H, CH), 3.28 (s, 3H, OCH3), 3.26 (br s, 1H, CH), 2.61
(s, 1H, CH), 2.29 (s, 3H, CH3), 1.04–1.01 (m, 3H, CH),
0.84–0.82 (m, 1H, CH), 0.74–0.71 (m, 6H, CH3); 13C NMR
(150 MHz, DMSO-d6) δ: 196.1, 173.7, 170.9, 169.5, 165.3,
164.5, 157.2 (d, J = 235.2 Hz), 146.3, 143.3, 139.3, 134.6,
138.7, 127.7, 124.5 (d, J = 8.9 Hz), 116.4 (d, J = 25.2 Hz),
114.8 (d, J = 23.1 Hz), 109.3 (d, J = 8.9 Hz), 95.1, 93.6, 58.4,
55.1, 53.4, 51.6, 50.9, 49.9, 47.8, 47.5, 43.0, 37.5, 28.5, 21.0,
19.2, 13.5; IR (KBr) υ: 3457, 2956, 1712, 1600, 1514, 1489,
1455, 1386, 1322, 1237, 1178, 1131, 1025, 962, 808, 758
cm−1; MS (m/z): HRMS (ESI) Calcd. for C44H42FN3NaO9
([M+Na]+): 798.2797. Found: 798.2783.
Spiro compounds (4d)
White solid, 85 %, m.p. 182–185 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.51 (d, J = 8.4 Hz, 2H, ArH), 7.46 (d, J
= 8.4 Hz, 2H, ArH), 7.11–7.08 (m, 1H, ArH), 7.05 (d, J
= 8.4 Hz, 2H, ArH), 6.91–6.90 (m, 3H, ArH), 6.57 (d, J =
8.4 Hz, 1H, ArH), 5.82 (d, J = 1.8 Hz, 1H, CH), 5.09 (s, 1H,
CH), 4.32 (br s, 1H, CH), 4.06 (s, 1H, CH), 4.00 (s, 3H,
OCH3), 3.80 (s, 3H, OCH3), 3.55–3.54 (m, 1H, CH), 3.48–
3.47 (m, 1H, CH), 3.35 (br s, 5H, CH, OCH3), 2.62 (s, 1H,
CH), 1.03 (br s, 3H, CH), 0.82 (brs, 1H, CH), 0.73–0.72 (m,
6H, CH3); 13C NMR (150 MHz, CDCl3) δ: 195.0, 174.7,
174.6, 173.6, 166.0, 165.1, 163.4, 158.5 (d, J = 239.9 Hz),
146.6, 141.7, 138.8, 134.7, 130.4, 129.8, 129.4, 127.4, 126.2
(d, J = 8.6 Hz), 123.0, 118.8 (d, J = 25.8 Hz), 115.1 (d,
J = 23.1 Hz), 113.4, 108.4 (d, J = 8.4 Hz), 96.6, 61.2, 55.4,
53.5, 51.9, 51.2, 50.5, 47.6, 46.0, 42.6, 40.2, 39.3, 29.0, 20.1,
19.7, 13.6; IR (KBr) υ: 3458, 2957, 1781, 1714, 1677, 1598,
1491, 1455, 1384, 1325, 1240, 1280, 1130, 1093, 1020, 960,
908, 868, 835, 807 cm−1; MS (m/z): HRMS (ESI) Calcd. for
C43H40ClFN3O9 ([M+H]+): 796.2432. Found: 796.2432.
Spiro compounds (4e)
White solid, 86 %, m.p. 230–233 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.53–7.49 (m, 4H, ArH), 7.09–7.06 (m, 1H,
ArH), 7.04 (d, J = 8.4 Hz, 2H, ArH), 6.92–6.90 (m, 3H, ArH),
6.60 (d, J = 8.4 Hz, 1H, ArH), 5.13 (s, 1H, CH), 4.63 (d, J
= 4.2 Hz, 1H, CH), 4.05 (br s, 1H, CH), 4.02 (s, 3H, OCH3),
3.99 (s, 1H, CH), 3.80 (s, 3H, OCH3), 3.58–3.56 (m, 1H,
CH), 3.48–3.43 (m, 1H, CH), 3.40–3.39 (m, 1H, CH), 3.36
(s, 3H, OCH3), 3.32 (br s, 1H, CH), 2.75 (s, 1H, CH), 1.46 (s,
3H, CH3), 1.03–1.01 (m, 1H, CH), 0.93–0.91 (m, 2H, CH),
0.80–0.79 (m, 1H, CH), 0.67 (d, J = 7.2 Hz, 3H, CH3); 13C
NMR (150 MHz, CDCl3) δ: 195.2, 175.1, 174.4, 173.4,
166.1, 165.2, 163.5, 158.3 (d, J = 240.2 Hz), 146.6, 139.6,
138.0, 134.7, 130.6, 130.2, 129.8, 129.4, 127.3, 127.2 (d, J =
8.9 Hz), 122.3, 117.4 (d, J = 25.5 Hz), 115.0 (d, J = 23.4 Hz),
113.4, 108.4 (d, J = 8.0 Hz), 97.0, 61.8, 55.7, 55.4, 53.5, 51.3,
50.4, 46.6, 45.0, 42.7, 40.2, 34.6, 29.0, 20.0, 19.5, 13.6; IR
(KBr) υ: 3457, 2958, 1747, 1712, 1601, 1492, 1446, 1426,
1384, 1355, 1318, 1264, 1236, 1175, 1138, 1022, 956, 918,
896, 876, 825, 803 cm−1; MS (m/z): HRMS (ESI) Calcd. for
C43H30ClFN3O9 ([M+H]+): 796.2432. Found: 796.2429.
Spiro compounds (4f)
White solid, 90 %, m.p. >300 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.43 (d, J = 4.8 Hz, 2H, ArH), 7.27 (d, J
= 7.2 Hz, 1H, ArH), 6.90 (br s, 3H, ArH), 6.84 (br s, 1H,
ArH), 5.50 (s, 1H, CH), 4.89 (d, J = 3.0 Hz, 1H, CH), 4.47
(brs, 1H, CH), 4.00 (s, 3H, OCH3), 3.98 (s, 1H, CH), 3.79
(s, 3H, OCH3), 3.77–3.75 (m, 1H, CH), 3.69 (br s, 1H, CH),
3.36 (br s, 4H, CH, OCH3), 3.26–3.24 (m, 1H, CH), 2.74 (s,
3H, OCH3), 2.54 (s, 1H, CH), 1.00 (br s, 3H, CH), 0.82–0.78
(m, 1H, CH), 0.70 (br s, 3H, CH3); IR (KBr) υ: 3453, 2957,
1861, 1779, 1699, 1675, 1641, 1584, 1511, 1483, 1455, 1433,
1368, 1342, 1321, 1269, 1232, 1203, 1170, 1129, 1086, 1049,
123
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1017, 972, 942, 924, 879, 841, 811 cm−1; MS (m/z): HRMS
(ESI) Calcd. for C37H35ClN2NaO11 ([M+Na]+): 741.1822.
Found: 741.1808.
Spiro compounds (4g)
White solid, 88 %, m.p. 283–285 ◦C; 1H NMR (600 MHz,
DMSO-d6) δ: 7.30 (d, J = 8.4 Hz, 2H, ArH), 7.17 (d, J
= 7.8 Hz, 2H, ArH), 7.08 (td, J1 = 9.3 Hz, J2 = 2.4 Hz, 1H,
ArH), 6.88 (dd, J1 = 8.4 Hz, J2 = 4.2 Hz, 1H, ArH), 6.61
(dd, J1 = 9.3 Hz, J2 = 2.4 Hz, 1H, ArH), 5.06 (s, 1H, CH),
4.92 (dd, J1 = 6.6 Hz, J2 = 2.4 Hz, 1H, CH), 4.48 (dd, J1 =
6.6 Hz, J2 = 3.6 Hz, 1H, CH), 4.00–3.99 (m, 4H, CH, OCH3),
3.76 (dd, J1 = 7.5 Hz, J2 = 3.6 Hz, 1H, CH), 3.67 (dd, J1 =
7.5 Hz, J2 = 3.6 Hz, 1H, CH), 3.36 (s, 3H, OCH3), 3.28–3.27
(m, 1H, CH), 3.20–3.19 (m, 1H, CH), 2.71 (s, 3H, OCH3),
2.56 (s, 1H, CH), 2.31 (s, 3H, CH3), 1.02 (br s, 3H, CH),
0.81–0.79 (m, 1H, CH), 0.71 (d, J = 7.2 Hz, 3H, CH3); 13C
NMR (150 MHz, DMSO-d6) δ: 194.8, 175.3, 174.2, 174.1,
165.4, 164.6, 163.1, 157.5 (d, J = 236.1 Hz), 146.5, 140.6,
139.0, 138.2, 130.0, 129.8, 129.4, 129.1, 126.3, 125.9 (d, J =
8.3 Hz), 122.7, 117.3 (d, J = 22.5 Hz), 114.7 (d, J = 23.3 Hz),
113.4, 109.3, 94.5, 60.2, 55.4, 53.3, 51.8, 50.8, 49.7, 47.0,
45.8, 42.1, 28.7, 20.6, 19.4, 19.2, 13.4; IR (KBr) υ: 3456,
2956, 1864, 1780, 1740, 1697, 1641, 1585, 1489, 1455, 1435,
1382, 1339, 1320, 1267, 1232, 1202, 1177, 1120, 1086, 1046,
1017, 979, 929, 872, 816, 792 cm−1; MS (m/z): HRMS (ESI)
Calcd. for C37H35FN2NaO10 ([M+Na]+): 709.2168. Found:
709.2158.
Supporting information
1H and 13C NMR spectra and 2D NMR for all new
compounds are available. Crystallographic data 1c (CCDC
916455), 1h (CCDC 916456), 1m (CCDC 916457), 2b
(CCDC 916458), 3e (CCDC 928874), 3i (CCDC 928875), 4d
(CCDC 928873) have been deposited at the Cambridge Crys-
tallographic Database Centre and are available on request
(http://www.ccdc.cam.ac.uk).
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